The stability of chemotherapeutic agents incorporated into agar plates was studied by comparison of minimum inhibitory concentrations on fresh and stored plates and by direct bioassay of the chemotherapeutic agar plates. Plates were stored in sealed bags at 4 C. No loss of bioactivity was demonstrated after 30 days of storage in plates containing methicillin, erythromycin, cephalothin, tetracycline, chloramphenicol, kanamycin, streptomycin, polymyxin B, or nalidixic acid. Penicillin G, ampicillin, and nitrofurantoin showed statistically significant losses of activity after 4 weeks. None of the chemotherapeutics tested showed significant loss in activity after 1 week.
The stability of many antibiotics and chemotherapeutics in the dry state and in aqueous solution has been established (6) . Less is known about their stability in nutrient agar. This is important in the use of the agar dilution susceptibility test method, because its practicability as a routine method depends partly on how long plates containing clinically relevant concentrations of chemotherapeutics can be stored without deterioration. (The term "chemotherapeutics" is used throughout to include antibiotics.) The two studies reported here were designed to provide this information. The first involved agar dilution susceptibility tests of 29 bacterial strains by using both freshly prepared and stored plates to determine any changes of inhibitory end points. The second used a more sensitive direct agar diffusion bioassay technique to determine the amounts of active chemotherapeutic in agar plates after various periods of storage. These studies were done as part of an international collaborative study on antibiotic susceptibility testing.
MATERIALS AND METHODS
Chemotherapeutics. The 13 agents listed in Tables 1  and 2 were tested. Standard powders of known activity were obtained from the manufacturers. Stock solutions containing 1,280 pg/ml or units/ml (polymyxin) of the chemotherapeutic were prepared by solubilizing them in sterile water or saline. Erythromycin and chloramphenicol were first dissolved in a minimum amount of absolute ethyl alcohol, and nalidixic acid was similarly solubilized with a minimum amount of 0.1 N NaOH. The chemotherapeutic stock solutions were stored at -20 C or below in small portions. They were discarded after use and never refrozen.
Media. Nutrient agar (Difco) and Trypticase Soy Agar (BBL) were used for the first part of the study, and Mueller-Hinton agar (Difco) was used for the second part. They were prepared from the dehydrated media as directed by the manufacturer.
Organisms. The 29 organisms used in the first part of the study were recent isolates from the clinical microbiology laboratories at the Mayo Clinic. They comprised six isolates each of Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, and Enterobacter sp. and five isolates of Pseudomonas aeruginosa. They were purified by two successive single-colony isolations and stored at room temperature on nutrient agar slants under sterile mineral oil.
The assay strains used in the second part of the study were Sarcina lutea ATCC 9341 (ampicillin, methicillin, penicillin G, erythromycin, chloramphenicol, and tetracycline), Bacillus subtilis (kanamycin), S. aureus (cephalothin and streptomycin), Bordetella bronchiseptica ATCC 4617 (polymyxin B), and Shigella C (nalidixic acid and nitrofurantoin). The S. aureus and Shigella C strains were isolated in the clinical microbiology laboratories of the University of Washington Hospital. They were known to be consistently susceptible to the agents assayed through previous testing. The B. subtilis strain was the same one used by Bennett et al. (1) .
Preparation of chemotherapeutic-containing plates.
For the first part of the study, each chemotherapeutic was added to 100-ml volumes of melted agar at 48 C to give twofold dilutions of chemotherapeutics over a clinically significant range. Tables 2 and 3 . Sets of plates were prepared at various intervals of as long as 4 weeks before the assays were to be performed and again sealed in Mylar bags and held at 4 C. One set was prepared immediately before each assay as a standard.
Agar dilution susceptibility tests. For the first part of the study, the test organisms were transferred to tubes of nutrient broth 24 hr before the tests were to be performed. After overnight incubation, one loopful of growth was transferred to another tube of broth and incubated for 6 hr. The resulting growth served as the inoculum and was applied to the surface of the agar plates with a Steers imprinter (5). This apparatus permitted all 29 strains to be tested simultaneously. The plates were incubated for 18 hr at 37 C. The lowest concentration of chemotherapeutic inhibiting growth completely as judged by the naked eye was taken as the minimum inhibitory concentration (MIC) of the chemotherapeutic for the organisms. Simultaneous tests were always done on freshly prepared plates when stored plates were being tested.
Assay of antibiotic in agar. Large assay plates [9 by 9 inches (22.9 by 22.9 cm)] were prepared containing Trypticase Soy Agar (BBL) with 1% yeast extract (Difco) seeded with the appropriate assay strain for the agent under investigation. The method followed that previously described by Dunsmoor, Pim, and Sherris (2). A 75-ml amount of agar was used for the cephalothin, chloramphenicol, streptomycin, and tetracycline assays, and 150 ml was used for the other agents. Preliminary experiments had shown these to be the optimal conditions with the chemotherapeutic concentrations and assay strains used. To assay the residual antibiotic in the stored plates, 9-mm plugs of agar were taken from their centers by using a cork borer. The plugs were then carefully placed on the surface of the assay plate. Plugs from each freshly prepared standard plate were similarly treated. In the case of cephalothin, chloramphenicol, tetracycline, kanamycin, nalidixic acid, and nitrofurantoin, the sensitivity of the assay was slightly improved by placing two plugs one on top of the other, and this procedure was used for the unknowns and standards with these agents only. After placing all of the plugs, the assay plates were covered with a glass plate and incubated for 18 hr at 37 C. Zones of inhibition around the plugs were measured with calipers and recorded. Duplicate plugs from the test plates and quadruplicate plugs from the standards were used for the experiment summarized in Table 2 . Six replicates were used in all cases for that shown in (3) were performed to compare the zone size measurements from unstored plates (0 time) with those stored for 1 and 4 weeks. The only significant differences were with the 4-week-old penicillin G, ampicillin, and nitrofurantoin plates. These showed differences significant at the 1% level. None of the plates stored for 1 week showed significant differences from the standards at either the 1 or 5% levels. (4, 6) . The statistical analysis of repeat bioassays confirmed significant deterioration of ampicillin and penicillin G after 4 weeks of storage but not deterioration of methicillin. In addition, nitrofurantoin activity was significantly less after 4 weeks of storage. Loss of activity in each of these cases was less than 25%. None of the chemotherapeutics tested showed significant loss of bioactivity after 1 week of storage.
For practical purposes, it appears safe, with any of the chemotherapeutics tested here, to prepare chemotherapeutic-agar plates on a weekly schedule, storing them in sealed bags at 4 C until used. It also appears possible to hold some antibiotics in this form for longer periods if small losses of activity can be accepted and if other changes which may take place in the medium are acceptable. 
